Showing results 8 to 27 of 30
< previous
next >
| Issue Date | Title | Author(s) |
| 2021 | Emerging role of circulating tumor cells in immunotherapy. | Rzhevskiy, A; Kapitannikova, A; Malinina, P; Volovetsky, A; Aboulkheyr Es, H; Kulasinghe, A; Thiery, JP; Maslennikova, A; Zvyagin, AV; Ebrahimi Warkiani, M |
| 2020-10-26 | Emerging Standards and the Hybrid Model for Organizing Scientific Events During and After The COVID-19 Pandemic. | Hanaei, S; Takian, A; Majdzadeh, R; Maboloc, CR; Grossmann, I; Gomes, O; Milosevic, M; Gupta, M; Shamshirsaz, AA; Harbi, A; Burhan, AM; Uddin, LQ; Kulasinghe, A; Lam, C-M; Ramakrishna, S; Alavi, A; Nouwen, JL; Dorigo, T; Schreiber, M; Abraham, A; Shelkovaya, N; Krysztofiak, W; Ebrahimi Warkiani, M; Sellke, F; Ogino, S; Barba, FJ; Brand, S; Vasconcelos, C; Salunke, DB; Rezaei, N |
| 2017-02-15 | Enrichment of circulating head and neck tumour cells using spiral microfluidic technology | Kulasinghe, A; Tran, THP; Blick, T; O'Byrne, K; Thompson, EW; Warkiani, ME; Nelson, C; Kenny, L; Punyadeera, C |
| 2020-10 | Ex vivo culture of circulating tumour cells derived from non-small cell lung cancer. | Kapeleris, J; Kulasinghe, A; Warkiani, ME; Oleary, C; Vela, I; Leo, P; Sternes, P; O'Byrne, K; Punyadeera, C |
| 2020-11-27 | High-Plex and High-Throughput Digital Spatial Profiling of Non-Small-Cell Lung Cancer (NSCLC). | Monkman, J; Taheri, T; Ebrahimi Warkiani, M; O'Leary, C; Ladwa, R; Richard, D; O'Byrne, K; Kulasinghe, A |
| 2021 | <i>IFI27</i> transcription is an early predictor for COVID-19 outcomes; a multi-cohort observational study | Shojaei, M; Shamshirian, A; Monkman, J; Grice, L; Tran, M; Tan, CW; Rossi, GR; McCulloch, T; Nalos, M; Chew, KY; Zhu, Y; Xia, Y; Wells, T; Senegaglia, AC; Rebelatto, CLK; Franck, CL; dos Santos, AFR; de Noronha, L; Motamen, S; Valadan, R; Amjadi, O; Gogna, R; Madan, E; Alizadeh-Navaei, R; Lamperti, L; Zuñiga, F; Nova-Lamperti, E; Labarca, G; Knippenberg, B; Herwanto, V; Wang, Y; Phu, A; Chew, T; Kwan, T; Kim, K; Teoh, S; Pelaia, T; Kuan, WS; Jee, Y; Iredell, J; O’Byrne, K; Fraser, J; Davis, M; Belz, G; Warkiani, M; Gallo, CS; Souza-Fonseca-Guimaraes, F; Nguyen, Q; Mclean, A; Kulasinghe, A; Short, K; Tang, B |
| 2022 | IFI27 transcription is an early predictor for COVID-19 outcomes, a multi-cohort observational study. | Shojaei, M; Shamshirian, A; Monkman, J; Grice, L; Tran, M; Tan, CW; Teo, SM; Rodrigues Rossi, G; McCulloch, TR; Nalos, M; Raei, M; Razavi, A; Ghasemian, R; Gheibi, M; Roozbeh, F; Sly, PD; Spann, KM; Chew, KY; Zhu, Y; Xia, Y; Wells, TJ; Senegaglia, AC; Kuniyoshi, CL; Franck, CL; Dos Santos, AFR; de Noronha, L; Motamen, S; Valadan, R; Amjadi, O; Gogna, R; Madan, E; Alizadeh-Navaei, R; Lamperti, L; Zuñiga, F; Nova-Lamperti, E; Labarca, G; Knippenberg, B; Herwanto, V; Wang, Y; Phu, A; Chew, T; Kwan, T; Kim, K; Teoh, S; Pelaia, TM; Kuan, WS; Jee, Y; Iredell, J; O'Byrne, K; Fraser, JF; Davis, MJ; Belz, GT; Warkiani, ME; Gallo, CS; Souza-Fonseca-Guimaraes, F; Nguyen, Q; Mclean, A; Kulasinghe, A; Short, KR; Tang, B |
| 2023-02 | Immunotherapeutic targets in non-small cell lung cancer. | Sadeghirad, H; Bahrami, T; Layeghi, SM; Yousefi, H; Rezaei, M; Hosseini-Fard, SR; Radfar, P; Warkiani, ME; O'Byrne, K; Kulasinghe, A |
| 2021-06-03 | Isolation of Circulating Tumour Cells in Patients With Glioblastoma Using Spiral Microfluidic Technology – A Pilot Study | Bark, JM; Kulasinghe, A; Hartel, G; Leo, P; Warkiani, ME; Jeffree, RL; Chua, B; Day, BW; Punyadeera, C |
| 2017-05-16 | PD-L1 expressing circulating tumour cells in head and neck cancers | Kulasinghe, A; Perry, C; Kenny, L; Warkiani, ME; Nelson, C; Punyadeera, C |
| 2019-03-18 | Phenotypic Characterization of Circulating Lung Cancer Cells for Clinically Actionable Targets. | Kulasinghe, A; Kapeleris, J; Cooper, C; Warkiani, ME; O'Byrne, K; Punyadeera, C |
| 2018-08-14 | The prognostic role of circulating tumor cells (CTCs) in lung cancer | Kapeleris, J; Kulasinghe, A; Warkiani, ME; Vela, I; Kenny, L; O'Byrne, K; Punyadeera, C |
| 2016-09-13 | Short term ex-vivo expansion of circulating head and neck tumour cells. | Kulasinghe, A; Perry, C; Warkiani, ME; Blick, T; Davies, A; O'Byrne, K; Thompson, EW; Nelson, CC; Vela, I; Punyadeera, C |
| 2022-09 | Single-cell analysis of circulating tumour cells: enabling technologies and clinical applications. | Radfar, P; Aboulkheyr Es, H; Salomon, R; Kulasinghe, A; Ramalingam, N; Sarafraz-Yazdi, E; Thiery, JP; Warkiani, ME |
| 2021 | The Effects of COVID-19 on the Placenta During Pregnancy. | Rad, HS; Röhl, J; Stylianou, N; Allenby, MC; Bazaz, SR; Warkiani, ME; Guimaraes, FSF; Clifton, VL; Kulasinghe, A |
| 2020-01 | The evolving landscape of predictive biomarkers in immuno-oncology with a focus on spatial technologies. | Sadeghi Rad, H; Bazaz, SR; Monkman, J; Ebrahimi Warkiani, M; Rezaei, N; O'Byrne, K; Kulasinghe, A |
| 2021-07-19 | The Pandora’s Box of novel technologies that may revolutionize lung cancer | Rad, HS; Rad, HS; Shiravand, Y; Radfar, P; Arpon, D; Warkiani, ME; O'Byrne, K; Kulasinghe, A |
| 2021 | The Role of Circulating Biomarkers in Lung Cancer. | Herath, S; Sadeghi Rad, H; Radfar, P; Ladwa, R; Warkiani, M; O'Byrne, K; Kulasinghe, A |
| 2020-06-15 | The Use of Three-Dimensional DNA Fluorescent In Situ Hybridization (3D DNA FISH) for the Detection of Anaplastic Lymphoma Kinase (ALK) in Non-Small Cell Lung Cancer (NSCLC) Circulating Tumor Cells. | Kulasinghe, A; Lim, Y; Kapeleris, J; Warkiani, M; O'Byrne, K; Punyadeera, C |
| 2021-01-01 | Understanding the tumor microenvironment for effective immunotherapy. | Sadeghi Rad, H; Monkman, J; Warkiani, ME; Ladwa, R; O'Byrne, K; Rezaei, N; Kulasinghe, A |
